{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:43:23Z","timestamp":1747161803982,"version":"3.40.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.htct.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T10:52:31Z","timestamp":1675939951000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the knowledge of hematologists about the management of infectious complications in hematologic patients"],"prefix":"10.1016","volume":"46","author":[{"given":"Mariana","family":"Guarana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-0014","authenticated-orcid":false,"given":"Marcio","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.htct.2023.01.003_bib0001","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.htct.2023.01.003_bib0002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hoc.2010.11.008","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"25","author":"Wingard","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.htct.2023.01.003_bib0003","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cmi.2015.01.003","article-title":"Blood culture-based diagnosis of bacteraemia: state of the art","volume":"21","author":"Opota","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.htct.2023.01.003_bib0004","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1373\/jalm.2018.027318","article-title":"The use of Matrix-Assisted Laser Desorption\/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for the identification of pathogens causing sepsis","volume":"3","author":"Luethy","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"9","key":"10.1016\/j.htct.2023.01.003_bib0005","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.htct.2023.01.003_bib0006","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation beta-lactam\/beta-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.htct.2023.01.003_bib0007","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40262-013-0086-1","article-title":"Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations","volume":"52","author":"Goulenok","year":"2013","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.htct.2023.01.003_bib0008","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QCO.0000000000000740","article-title":"Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions","volume":"34","author":"Lewis","year":"2021","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.htct.2023.01.003_bib0009","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1078155219848817","article-title":"Perception of hematologists and oncologists about the biosimilars: a prospective Tunisian study based on a survey","volume":"26","author":"Hadoussa","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.htct.2023.01.003_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-3148.2011.01118.x","article-title":"A survey to assess transfusion medicine education needs for clinicians","volume":"22","author":"Arinsburg","year":"2012","journal-title":"Transfus Med"},{"issue":"3","key":"10.1016\/j.htct.2023.01.003_bib0011","doi-asserted-by":"crossref","first-page":"e28786","DOI":"10.1002\/pbc.28786","article-title":"Evaluation of knowledge and comfort with opioid prescribing among pediatric hematology\/oncology fellows","volume":"68","author":"MacDonell-Yilmaz","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.htct.2023.01.003_bib0012","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/trf.15390","article-title":"Evaluation of immunohematology knowledge in hematology trainees","volume":"59","author":"Yan","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.htct.2023.01.003_bib0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12185-020-02921-x","article-title":"Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group","volume":"112","author":"Kimura","year":"2020","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.htct.2023.01.003_bib0014","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s15010-020-01462-z","article-title":"Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland","volume":"48","author":"Scheler","year":"2020","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.htct.2023.01.003_bib0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cmi.2015.06.007","article-title":"Use of old antibiotics now and in the future from a pharmacokinetic\/pharmacodynamic perspective","volume":"21","author":"Muller","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.htct.2023.01.003_bib0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/clinids\/18.1.25","article-title":"Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors","volume":"18","author":"Bochud","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.htct.2023.01.003_bib0017","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0959-8049(03)00272-7","article-title":"Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors","volume":"39","author":"Paganini","year":"2003","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.htct.2023.01.003_bib0018","first-page":"179","article-title":"Recommendations for the management of candidemia in adults in Latin America. Latin America Invasive Mycosis Network","volume":"30","author":"Nucci","year":"2013","journal-title":"Rev Iberoam Micol"},{"issue":"11","key":"10.1016\/j.htct.2023.01.003_bib0019","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/17474086.2016.1242406","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection","volume":"9","author":"Locatelli","year":"2016","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"10.1016\/j.htct.2023.01.003_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bmt.1700498","article-title":"Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group","volume":"19","author":"Prentice","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"10020","key":"10.1016\/j.htct.2023.01.003_bib0021","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T21:42:15Z","timestamp":1716414135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137923000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2531137923000287"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.01.003","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the knowledge of hematologists about the management of infectious complications in hematologic patients","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}